113 related articles for article (PubMed ID: 12796033)
1. Loss of atm sensitises p53-deficient cells to topoisomerase poisons and antimetabolites.
Fedier A; Schlamminger M; Schwarz VA; Haller U; Howell SB; Fink D
Ann Oncol; 2003 Jun; 14(6):938-45. PubMed ID: 12796033
[TBL] [Abstract][Full Text] [Related]
2. Increased sensitivity of p53-deficient cells to anticancer agents due to loss of Pms2.
Fedier A; Ruefenacht UB; Schwarz VA; Haller U; Fink D
Br J Cancer; 2002 Oct; 87(9):1027-33. PubMed ID: 12434296
[TBL] [Abstract][Full Text] [Related]
3. The effect of loss of Brca1 on the sensitivity to anticancer agents in p53-deficient cells.
Fedier A; Steiner RA; Schwarz VA; Lenherr L; Haller U; Fink D
Int J Oncol; 2003 May; 22(5):1169-73. PubMed ID: 12684687
[TBL] [Abstract][Full Text] [Related]
4. Topoisomerase poisons differentially activate DNA damage checkpoints through ataxia-telangiectasia mutated-dependent and -independent mechanisms.
Siu WY; Lau A; Arooz T; Chow JP; Ho HT; Poon RY
Mol Cancer Ther; 2004 May; 3(5):621-32. PubMed ID: 15141020
[TBL] [Abstract][Full Text] [Related]
5. p53-deficient cells display increased sensitivity to anthracyclines after loss of the catalytic subunit of the DNA-dependent protein kinase.
Fedier A; Moawad A; Haller U; Fink D
Int J Oncol; 2003 Nov; 23(5):1431-7. PubMed ID: 14532987
[TBL] [Abstract][Full Text] [Related]
6. Role of p53 and ATM in photodynamic therapy-induced apoptosis.
Heinzelmann-Schwarz V; Fedier A; Hornung R; Walt H; Haller U; Fink D
Lasers Surg Med; 2003; 33(3):182-9. PubMed ID: 12949948
[TBL] [Abstract][Full Text] [Related]
7. Etoposide induces G2/M arrest and apoptosis in neural progenitor cells via DNA damage and an ATM/p53-related pathway.
Nam C; Doi K; Nakayama H
Histol Histopathol; 2010 Apr; 25(4):485-93. PubMed ID: 20183801
[TBL] [Abstract][Full Text] [Related]
8. Assessment of ATM phosphorylation on Ser-1981 induced by DNA topoisomerase I and II inhibitors in relation to Ser-139-histone H2AX phosphorylation, cell cycle phase, and apoptosis.
Kurose A; Tanaka T; Huang X; Halicka HD; Traganos F; Dai W; Darzynkiewicz Z
Cytometry A; 2005 Nov; 68(1):1-9. PubMed ID: 16184611
[TBL] [Abstract][Full Text] [Related]
9. S phase and G2 arrests induced by topoisomerase I poisons are dependent on ATR kinase function.
Cliby WA; Lewis KA; Lilly KK; Kaufmann SH
J Biol Chem; 2002 Jan; 277(2):1599-606. PubMed ID: 11700302
[TBL] [Abstract][Full Text] [Related]
10. p53-Independent apoptosis disrupts early organogenesis in embryos lacking both ataxia-telangiectasia mutated and Prkdc.
Gladdy RA; Nutter LM; Kunath T; Danska JS; Guidos CJ
Mol Cancer Res; 2006 May; 4(5):311-8. PubMed ID: 16687486
[TBL] [Abstract][Full Text] [Related]
11. Relationship between DNA double-strand break rejoining and cell survival after exposure to ionizing radiation in human fibroblast strains with differing ATM/p53 status: implications for evaluation of clinical radiosensitivity.
Mirzayans R; Severin D; Murray D
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1498-505. PubMed ID: 17126209
[TBL] [Abstract][Full Text] [Related]
12. The plant isoflavenoid genistein activates p53 and Chk2 in an ATM-dependent manner.
Ye R; Bodero A; Zhou BB; Khanna KK; Lavin MF; Lees-Miller SP
J Biol Chem; 2001 Feb; 276(7):4828-33. PubMed ID: 11096068
[TBL] [Abstract][Full Text] [Related]
13. Enhanced cytotoxicity of PARP inhibition in mantle cell lymphoma harbouring mutations in both ATM and p53.
Williamson CT; Kubota E; Hamill JD; Klimowicz A; Ye R; Muzik H; Dean M; Tu L; Gilley D; Magliocco AM; McKay BC; Bebb DG; Lees-Miller SP
EMBO Mol Med; 2012 Jun; 4(6):515-27. PubMed ID: 22416035
[TBL] [Abstract][Full Text] [Related]
14. Genetic interactions between atm and p53 influence cellular proliferation and irradiation-induced cell cycle checkpoints.
Westphal CH; Schmaltz C; Rowan S; Elson A; Fisher DE; Leder P
Cancer Res; 1997 May; 57(9):1664-7. PubMed ID: 9135004
[TBL] [Abstract][Full Text] [Related]
15. c-Abl is required for development and optimal cell proliferation in the context of p53 deficiency.
Whang YE; Tran C; Henderson C; Syljuasen RG; Rozengurt N; McBride WH; Sawyers CL
Proc Natl Acad Sci U S A; 2000 May; 97(10):5486-91. PubMed ID: 10805805
[TBL] [Abstract][Full Text] [Related]
16. Resistance to topoisomerase poisons due to loss of DNA mismatch repair.
Fedier A; Schwarz VA; Walt H; Carpini RD; Haller U; Fink D
Int J Cancer; 2001 Aug; 93(4):571-6. PubMed ID: 11477562
[TBL] [Abstract][Full Text] [Related]
17. Regulator of G protein signaling 6 mediates doxorubicin-induced ATM and p53 activation by a reactive oxygen species-dependent mechanism.
Huang J; Yang J; Maity B; Mayuzumi D; Fisher RA
Cancer Res; 2011 Oct; 71(20):6310-9. PubMed ID: 21859827
[TBL] [Abstract][Full Text] [Related]
18. Isolation of camptothecin-sensitive chinese hamster cell mutants: phenotypic heterogeneity within the ataxia telangiectasia-like XRCC8 (irs2) complementation group.
Johnson MA; Bryant PE; Jones NJ
Mutagenesis; 2000 Jul; 15(4):367-74. PubMed ID: 10887218
[TBL] [Abstract][Full Text] [Related]
19. ATM is activated in response to N-methyl-N'-nitro-N-nitrosoguanidine-induced DNA alkylation.
Adamson AW; Kim WJ; Shangary S; Baskaran R; Brown KD
J Biol Chem; 2002 Oct; 277(41):38222-9. PubMed ID: 12151394
[TBL] [Abstract][Full Text] [Related]
20. Functional interaction of H2AX, NBS1, and p53 in ATM-dependent DNA damage responses and tumor suppression.
Kang J; Ferguson D; Song H; Bassing C; Eckersdorff M; Alt FW; Xu Y
Mol Cell Biol; 2005 Jan; 25(2):661-70. PubMed ID: 15632067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
